Molecular combing compared to Southern blot for measuring D4Z4 contractions in FSHD

Area of Science:

• Genetics
• Molecular Biology
• Clinical Diagnostics

Background:

• Facioscapulohumeral muscular dystrophy type 1 (FSHD1) diagnosis relies on analyzing the D4Z4 macrosatellite repeat array on chromosome 4q35.
• Southern blot is the conventional method for this analysis but has technical limitations.
• Molecular combing offers a potential alternative with direct visualization of DNA fragments.

Purpose of the Study:

• To compare the analytical validity of molecular combing against Southern blot for FSHD1 genetic testing.
• To assess molecular combing's ability to accurately size D4Z4 repeat arrays, detect mosaicism, and resolve ambiguous results.
• To evaluate molecular combing's performance on clinical genomic DNA specimens.

Main Methods:

• A blinded study re-analyzed 87 de-identified genomic DNA specimens using molecular combing.
• Specimens were previously characterized by Southern blot as normal, abnormal (with D4Z4 contractions), indeterminate, borderline, or mosaic.
• Molecular combing results were compared to the established Southern blot diagnoses.

Main Results:

• Molecular combing achieved 86% concordance with Southern blot results across all categories.
• All D4Z4 contractions and mosaic cases identified by Southern blot were confirmed by molecular combing.
• Molecular combing resolved all indeterminate Southern blot results and identified discrepancies in normal and borderline cases, including mosaicism and rearrangements.

Conclusions:

• Molecular combing demonstrates superior analytical validity compared to Southern blot for D4Z4 repeat analysis in FSHD testing.
• The technique provides direct visualization, precise sizing, and improved detection of mosaicism and borderline/indeterminate results.
• Further research is warranted to establish clinical validity and diagnostic accuracy for FSHD.